Hormone Receptor Positive Breast Carcinoma trials recruiting in Indiana

Fewer than 3 recruiting trials found.

All Hormone Receptor Positive Breast Carcinoma trials nationally

Cities in Indiana

Recruiting trials in Indiana

• Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
  NCT06058377 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Indiana: Crown Point, Dyer, Hobart, Indianapolis
• Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer
  NCT04553770 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Indiana: Fort Wayne